Drug intelligence / Profile preview

immune serum globulin

Development stage
Phase 4
Modality
Recombinant Proteins and Enzymes
Administration
Intramuscular, Intravenous, Subcutaneous
01

Overview

Immune serum globulin is a **sterile solution of immunoglobulin G (IgG) purified from pooled human plasma**, used primarily for passive immunization against infections such as hepatitis A, measles, varicella (chickenpox), and rubella, and as immunoglobulin replacement in individuals with antibody deficiencies. The product works by providing exogenous IgG antibodies, which confer **immediate, short-term protection** by neutralizing pathogens or their toxins, modulating immune responses, and supporting immune-deficient individuals. It is used both at replacement dosing (antibody deficiency) and higher immunomodulatory doses for various autoimmune, neurologic, hematologic, and dermatologic conditions. The mechanism involves **neutralization of viruses and toxins, modulation of Fc receptor function, inhibition of pathogenic autoantibodies, and anti-inflammatory immunomodulation**[1][2][3][7][9][10].

Brand names
HizentraPrivigenGammagard LiquidFlebogammaCutaquigXembifyCuvitruXepolGamunex-CGammakedOctagamPanzyga
Other names
immune globulin humanimmune globulingamma globulinimmunoglobulinISGimmune serum globulin humanimmune serumimmunoglobulin G
02

Targets

FCGRT (Neonatal crystallizable fragment receptor)CD209 (Dendritic cell-specific intercellular adhesion Molecule-3-Grabbing non-integrin)FcγR (Low affinity immunoglobulin gamma Fc region receptor II-c)

Beyond the preview

Go deeper on immune serum globulin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on immune serum globulin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call